AZD5423 / AstraZeneca  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD5423 / AstraZeneca
NCT01225549: The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen

Completed
2
27
Canada
AZD5423, Budesonide 200 microgram, Pulmicort, Placebo
AstraZeneca
Asthma
12/11
12/11
NCT01555099 / 2011-005389-39: Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol

Completed
2
353
Europe, RoW
AZD5423, Budesonide, Placebo
AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
04/13
04/13

Download Options